HCW Biologics Inc.
NASDAQ:HCWB
Overview | Financials
Company Name | HCW Biologics Inc. |
Symbol | HCWB |
Currency | USD |
Price | 0.342 |
Market Cap | 12,950,732 |
Dividend Yield | 0% |
52-week-range | 0.276 - 2.52 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Hing C. Wong Ph.D. |
Website | https://www.hcwbiologics.com |
An error occurred while fetching data.
About HCW Biologics Inc.
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD